It has been found that there was less expression of HIF-2α protein in normal tissues and organs but it was expressed in many tumor cells (such as endometrial cancer, bladder cancer, renal cell carcinoma, breast cancer, liver cancer, and prostate cancer cells) [12]. This evidence concerns the gene EPAS1 and urinary bladder cancer.